A detailed history of Wellington Management Group LLP transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 119,293 shares of ADMA stock, worth $2.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
119,293
Previous 598,228 80.06%
Holding current value
$2.08 Million
Previous $6.69 Million 64.35%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$11.21 - $20.03 $5.37 Million - $9.59 Million
-478,935 Reduced 80.06%
119,293 $2.38 Million
Q2 2024

Aug 13, 2024

SELL
$5.98 - $11.18 $86,889 - $162,445
-14,530 Reduced 2.37%
598,228 $6.69 Million
Q1 2024

May 15, 2024

BUY
$4.4 - $6.74 $2.7 Million - $4.13 Million
612,758 New
612,758 $4.04 Million
Q4 2023

Feb 12, 2024

BUY
$3.08 - $4.52 $659,073 - $967,212
213,985 New
213,985 $967,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.42B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.